Director, New Products and Business Development, Hematology

Johnson & Johnson Innovative MedicineHorsham, PA
Onsite

About The Position

Johnson and Johnson is recruiting for a Director, New Products & Business Development - Hematology to be located in Horsham, PA. Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. The Director, New Products & Business Development - Hematology will lead cross-functional US Integrated Strategy Teams and Launch Readiness to accelerate Johnson & Johnson Innovative Medicines' leadership in Hematology. The position is part of the US Hematology commercial organization. The Director will focus initially on Launch Readiness for Bleximenib, an investigational, oral menin inhibitor being developed to treat acute myeloid leukemia (AML).

Requirements

  • Minimum of 10 years of relevant business experience required.
  • Pharmaceutical marketing and launch experience required.
  • Ability to develop strategy and build business cases for new opportunities, including market overview, analytics, forecast development, and commercial resourcing required.
  • Strong verbal and written communication skills required
  • Strong decision-making skills
  • Ability to influence and impact cross-functionally through strong leadership and collaboration

Nice To Haves

  • Experience in Hematology / Oncology
  • Experience partnering with R&D, medical affairs, global marketing, market access, patient advocacy, and supply chain preferred

Responsibilities

  • Lead US Integrated Strategy Team (IST) to provide input into global compound strategy and Launch Readiness Team (LRT) as a core team member.
  • Lead US strategic planning including positioning, value proposition, Go-To-Market strategy, and inform US label planning, competitive vision, TPP, and value proposition for products going through the investment governance process.
  • Develop early market-shaping strategies including unbranded market development strategy, evidence generation, and KOL engagement.
  • Own governance (Launch Challenge Sessions & Launch Readiness Reviews) for Launch Readiness Teams leveraging the Launch Excellence guidance document, tools & resources.
  • Advise launch readiness team members on Launch Excellence Framework resources and providing feedback to shape continuous improvement of the Launch Excellence framework.
  • Lead US strategic planning, including positioning, value proposition, and informing US label planning.
  • Represent the US on the Global Commercial Team (GCT) to provide input to the Global Commercial Strategy Organization (GCSO).
  • Partner with GCSO on pipeline assets to ensure commercial insight drives clinical development plans
  • Collaborate with US NPBD Analytics to develop customer-insight-based forecasts and valuations to inform stage-gate decisions.
  • Lead early launch planning to shape thinking and ensure project deliverables are current and relevant; identifies gaps, risks, and potential impact to timelines.
  • Lead US input to select BD opportunities, including evaluation of competitive landscape, opportunity and required product attributes.

Benefits

  • inclusive work environment where each person is considered as an individual
  • respect the diversity and dignity of our employees and recognize their merit
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service